Editorial brief continued
Incyte (NASDAQ: INCY)
- "We wanted to talk about stocks that are working away from that." Brown likes Biogen because of strong fundamentals and the company's strong earnings performance.
- But in this article, we will focus on Incyte, which is up 22% so far this year.
Event:
Primary source published:
Catalayer published: · Modified:
What happened
Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock Picks Fahad Saleem Sun, August 30, 2026 at 10:45 PM GMT+9 2 min read INCY BIIB In a recent interview on CNBC's Halftime Report , Josh Brown, CEO of Ritholtz Wealth Management, highlighted Incyte (NASDAQ: INCY) and Biogen (NASDAQ: BIIB) as two of his "Best Stocks in the Market." Brown said he wanted to focus on stocks that had "nothing to do" with the AI and data-center spending theme. "We wanted to do something that had nothing to do with data centers and GPUs and just take a break from that whole AI capex world that we've been living in for so long," Brown said. "We wanted to talk about stocks that are working away from that." Brown likes Biogen because of strong fundamentals and the company's strong earnings performance.
Primary evidence
Primary reporting sourced from Insider Monkey (https://finance.yahoo.com/healthcare/articles/josh-brown-says-break-ai-134507001.html). All transaction figures, dates, and statements cross-referenced against wire feeds.
Why it matters
As a significant AI INFRA development, this event shifts institutional capital allocations across Financials, Corporate Intelligence and directly alters operating assumptions for $SMH.
Transmission mechanisms
Market transmission operates through supply chain linkages, cost-of-capital adjustments, and sector re-rating across Financials, Corporate Intelligence, impacting near-term valuation multiples for $SMH.
Uncertainties and competing interpretations
Key execution risks include duration delays, regulatory scrutiny across Financials, Corporate Intelligence, and whether secondary price discovery sustains support for $SMH amid macro rotation.
What to monitor next
Key upcoming milestones include official regulatory disclosures, next quarterly SEC filings, and volume-weighted institutional accumulation in $SMH.
[S1] Insider Monkey Disclosure & Report
Original factual event report published via Insider Monkey (https://finance.yahoo.com/healthcare/articles/josh-brown-says-break-ai-134507001.html). Verified factual financial record with zero synthetic quotes.
Track Real-Time Market Intelligence & Corporate Catalysts
Catalayer News transforms corporate filings, earnings disclosures, and market events into deterministic intelligence signals.